BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
3 hedge funds and large institutions have $100K invested in BIMI International Medical Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
1,150% more capital invested
Capital invested by funds: $8K → $100K (+$92K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$83.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$21.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
BIMI Hedge Fund Activity: Q4 2013 in Review
3 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q4 2013, worth a combined $100K — up 1,150% from $8K a quarter earlier.
Fund positioning in BIMI was balanced in Q4 2013: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $83.2K. The largest seller was UBS, exiting entirely with an estimated $4K sold.
- 3 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $100K of BIMI International Medical Inc. Common Stock stock for Q4 2013, up 1,150% quarter-over-quarter.
- 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q4 2013 and 2 closed out, a net change of 0 holders.
- The largest BIMI International Medical Inc. Common Stock buyer in Q4 2013 was Virtu KCG Holdings, an estimated $83.2K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q4 2013 was UBS, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2013.